Experience with norethisterone 0.35 mg. as an oral contraceptive - a preliminary report

Reference

• Martinez-Manautou, J., Giner-Velasquez, J., Cortes-Gallegos, V., Aznar, R., Rojas, B., Guitterez-Najar, A., and Rudel, H. W., (1967). Daily Progestogen for Contraception - a clinical study. Brit. med. J., 2, 730.1. Martinez-Manautou, J., Giner-Velasquez, J., Cortes-Gallegos, V., Aznar, R., Rojas, B., Guitterez-Najar, A., and Rudel, H. W., (1967). Daily Progestogen for Contraception - a clinical study. Brit. med. J., 2, 730.
   PubMed Web of Science ®Google Scholar
• Mears, E., Vessey, M. P., Andolsek, L., and Oven, A., (1969). Preliminary evaluation of four oral contraceptives containing only Progestogens. Brit. med. J., 2, 730.2. Mears, E., Vessey, M. P., Andolsek, L., and Oven, A., (1969). Preliminary evaluation of four oral contraceptives containing only Progestogens. Brit. med. J., 2, 730.
   PubMed Web of Science ®Google Scholar
• Butler, C., and Hill, H., (1969). Chlormadinone acetate as oral contraceptive. A clinical trial. Lancet, 1, 1116.3. Butler, C., and Hill, H., (1969). Chlormadinone acetate as oral contraceptive. A clinical trial. Lancet, 1, 1116.
   PubMed Web of Science ®Google Scholar
• Macdonald, R. R., Lumley, I. B., Coulson, A., and Stitch, S. R., (1968). Chlormadinone acetate as an oral contraceptive. Clinical results and the incidence of ovulation. J. Obstet. Gynaec. Brit. Cwlth., 75, 1123.4. Macdonald, R. R., Lumley, I. B., Coulson, A., and Stitch, S. R., (1968). Chlormadinone acetate as an oral contraceptive. Clinical results and the incidence of ovulation. J. Obstet. Gynaec. Brit. Cwlth., 75, 1123.
   PubMedGoogle Scholar
• Howard, G., Elstein, M., Blair, M., and Morris, N. F., (1969). Low-dose continuous chlormadinone acetate as an oral contraceptive. Lancet, 2, 24.5. Howard, G., Elstein, M., Blair, M., and Morris, N. F., (1969). Low-dose continuous chlormadinone acetate as an oral contraceptive. Lancet, 2, 24.
   PubMed Web of Science ®Google Scholar
• Elstein, M., (1968). Urinary hormone excretion patterns in chlormadinone acetate treated patients and the associated cervical mucus changes. Proc. Symp. on ‘Chlormadinone Acetate - a new departure in oral contraception’ (ed. A. George Christie and M. Moore-Robinson), p.46, Excerpta Medica Foundation, London.6. Elstein, M., (1968). Urinary hormone excretion patterns in chlormadinone acetate treated patients and the associated cervical mucus changes. Proc. Symp. on ‘Chlormadinone Acetate - a new departure in oral contraception’ (ed. George A. Christie and M. Moore-Robinson), p.46. Excerpta Medica Foundation, London.
   Google Scholar
• Macdonald, R. R., (1968). British experience with chlormadinone acetate. Proc. Symp. on ‘Chlormadinone Acetate - a new departure in oral contraception’ (ed.A. George Christie and M. Moore-Robinson), p.33, Excerpta Medica Foundation, London.7. Macdonald, R. R., (1968). British experience with chlormadinone acetate. Proc. Symp. on ‘Chlormadinone Acetate - a new departure in oral contraception’ (ed. George A. Christie and M. Moore-Robinson), p.33, Excerpta Medica Foundation, London.
   Google Scholar
• Fotherby, K., Kamyab, S., Littleton, P., and Klopper, A. I., (1968). Metabolism of synthetic progestational compounds in humans. J. Reprod. Fert., ( Supplement 5), 51. 8. Fotherby, K., Kamyab, S., Littleton, P., and Klopper, A. I., (1968). Metabolism of synthetic progestational compounds in humans. J. Reprod. Fert., (Supplement 5), 51.
   Google Scholar
• Larsson-Cohn, U., (1970). Contraceptive treatment with low doses of gestagens. Acta endocr., Copenh., ( Supplement 144), 13. 9. Larsson-Cohn, U., (1970). Contraceptive treatment with low doses of gestagens. Acta endocr., Copenh., (Supplement 144), 13.
   Google Scholar
• Potter, R. G. Jr., (1966). Application of life table techniques to measurement of contraceptive effectiveness. Demography, 3, 297.10. Potter, R. G. Jr., (1966). Application of life table techniques to measurement of contraceptive effectiveness. Demography, 3, 297.
   PubMed Web of Science ®Google Scholar
• Johansson, E. D. B., (1969). Progesterone levels in peripheral plasma during the luteal phase of the normal human menstrual cycle measured by a rapid competitive protein binding technique. Acta endocr., Copenh., 61, 592.11. Johansson, E. D. B., (1969). Progesterone levels in peripheral plasma during the luteal phase of the normal human menstrual cycle measured by a rapid competitive protein binding technique. Acta endocr., Copenh., 61, 592.
   PubMedGoogle Scholar
• Rudel, H., Lebherz, T., Maqueo-Topete, M., Martinez-Manautou, J., and Bessler, S., (1967). Assay of the anti-oestrogenic effects of progestogens in women. J. Reprod. Fert., 13, 199.12. Rudel, H., Lebherz, T., Maqueo-Topete, M., Martinez-Manautou, J., and Bessler, S., (1967). Assay of the anti-oestrogenic effects of progestogens in women. J. Reprod. Fert., 13, 199.
   PubMedGoogle Scholar
• Larsson-Cohn, U., (1969). The Serum Alanine Aminotransferase Activity and the Two-hour Sulphobromophthalein Retention Test during Daily Low-dose Gestagen Oral Contraceptive Treatment. Acta Soc. Med. upsal., 74, 283.13. Larsson-Cohn, U., (1969). The Serum Alanine Aminotransferase Activity and the Two-hour Sulphobromophthalein Retention Test during Daily Low-dose Gestagen Oral Contraceptive Treatment. Acta Soc. Med. upsal., 74, 283.
   PubMedGoogle Scholar
• Larsson-Cohn, U., Berlin, R., and Vikrot, O., (1970). Effects of combined and low-dose gestagen oral contraceptives on plasma lipids; including individual phospholipids. Acta endocr., Copenh., 63, 717.14. Larsson-Cohn, U., Berlin, R., and Vikrot, O., (1970). Effects of combined and low-dose gestagen oral contraceptives on plasma lipids; including individual phospholipids. Acta endocr., Copenh., 63, 717.
   PubMedGoogle Scholar
• Beck, R. P., Morcos, F., Fawcett, D., and Watanabe, M., (1972). Adrenocortical function studies during the normal menstrual cycle and in women receiving norethindrone with and without mestranol. Am. J. Obstet. Gynec., 112, 364.15. Beck, R. P., Morcos, F., Fawcett, D., and Watanabe, M., (1972). Adrenocortical function studies during the normal menstrual cycle and in women receiving norethindrone with and without mestranol. Am. J. Obstet. Gynec., 112, 364.
   PubMed Web of Science ®Google Scholar
• Potter, L., Thomson, Jean M., and Thomas, P. W., (1972). , In press.16. Potter, L., Thomson, Jean M., and Thomas, P. W., (1972). In press.
   Google Scholar